SS
Supriya Sadanand Sathe
About Supriya Sadanand Sathe
Data last updated:
Supriya Sadanand Sathe is a Director at Jay Shreeram Pharma Private Limited (since 2020). The company operates in Chemicals. Jay Shreeram Pharma Private Limited reported revenue of ₹2.3 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Sep 2020 | 2020 | ₹2.3 Lakh (FY 2024) | Active |
Board colleagues of Supriya Sadanand Sathe
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mahesh Vilas Awale | 08862017 | Jay Shreeram Pharma Private Limited | Director |
| Snehal Mahesh Awale | 08862018 | Jay Shreeram Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Supriya Sadanand Sathe
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Supriya Sadanand Sathe
Supriya Sadanand Sathe currently holds 1 directorship: Jay Shreeram Pharma Private Limited (Director, since 03 Sep 2020, revenue ₹2.3 Lakh (FY 2024)).
Supriya Sadanand Sathe was first appointed on 03 Sep 2020 as Director at Jay Shreeram Pharma Private Limited.
The current boards of Supriya Sadanand Sathe's companies include Mahesh Vilas Awale (Jay Shreeram Pharma Private Limited), Snehal Mahesh Awale (Jay Shreeram Pharma Private Limited).